# Do LRG1–SERPINA1 Interactions Modulate Fibrotic and Inflammatory Signatures in Rheumatoid Arthritis? A Proteomic and In Silico Investigation

**Authors:** Talib Hussain, Monika Verma, Sagarika Biswas

PMC · DOI: 10.3390/pathophysiology33010016 · Pathophysiology · 2026-02-06

## TL;DR

This study explores how LRG1 and SERPINA1 proteins interact in rheumatoid arthritis, potentially driving inflammation and fibrosis.

## Contribution

The novel contribution is identifying a potential inhibitory interaction between LRG1 and SERPINA1 that could promote RA-related inflammation and fibrosis.

## Key findings

- LRG1 and SERPINA1 show high co-expression in RA-related gene clusters.
- In silico simulations suggest strong interaction between LRG1 and SERPINA1.
- LRG1 may disrupt SERPINA1's anti-inflammatory role, promoting fibrotic and inflammatory processes.

## Abstract

Background: Rheumatoid arthritis (RA) is a systemic, pro-inflammatory, autoimmune disease that mainly affects the joints in a symmetrical manner. Differential proteomic profiling through Sequential Window Acquisition of all Theoretical Fragment Ion Mass Spectra (SWATH-MS/MS) helps in a better understanding of the RA pathogenesis. In this study, we compared the differentially upregulated proteins with those associated with fibrosis to gain a deeper understanding of the fibrotic aspect of RA. Methods: We analyzed plasma proteomics data, previously obtained by SWATH-MS/MS. Our focus was on proteins associated with Leucine Rich Alpha2glycoprotein1 (LRG1) and we employed an in silico method. Results: We identified common proteins between RA and fibrosis. Among them, LRG1 and Serine Protease Inhibitor Clade A, Member 1 (SERPINA1) showed a high co-expression score in the gene clusters. LRG1 is both pro-inflammatory and pro-fibrotic, while SERPINA1 is an anti-inflammatory protein that inhibits pro-inflammatory and pro-fibrotic molecules (Elastase). Further, docking studies and a simulation study of the docked complexes with the analysis of Hydrogen bonds, Solvent Accessible Surface Area (SASA), Root Mean Square Deviation (RMSD), Root Mean Square Fluctuation (RMSF) and Radius of gyration (Rg), suggested a strong interaction between the two partners, LRG1 and SERPINA1. Conclusions: Our study suggests that LRG1 may inhibit SERPINA1 and promote inflammation and fibrotic processes by disrupting SERPINA1’s primary function.

## Linked entities

- **Genes:** LRG1 (leucine rich alpha-2-glycoprotein 1) [NCBI Gene 116844], SERPINA1 (serpin family A member 1) [NCBI Gene 5265]
- **Proteins:** LRG1 (leucine rich alpha-2-glycoprotein 1), SERPINA1 (serpin family A member 1), cela1.2.L (chymotrypsin like elastase 1, gene 2 L homeolog)
- **Diseases:** Rheumatoid arthritis (MONDO:0008383)

## Full-text entities

- **Genes:** IL6R (interleukin 6 receptor) [NCBI Gene 3570] {aka CD126, HIES5, IL-1Ra, IL-6R, IL-6R-1, IL-6RA}, KRT6A (keratin 6A) [NCBI Gene 3853] {aka CK-6C, CK-6E, CK6A, CK6C, CK6D, K6A}, ACTA1 (actin alpha 1, skeletal muscle) [NCBI Gene 58] {aka ACTA, ASMA, CFTD, CFTD1, CFTDM, CMYO2A}, Lrg1 (leucine-rich alpha-2-glycoprotein 1) [NCBI Gene 76905] {aka 1300008B03Rik, 2310031E04Rik, Lrg, Lrhg}, Crp (C-reactive protein, pentraxin-related) [NCBI Gene 12944], TNF (tumor necrosis factor) [NCBI Gene 7124] {aka DIF, IMD127, TNF-alpha, TNFA, TNFSF2, TNLG1F}, Clu (clusterin) [NCBI Gene 12759] {aka ApoJ, Cli, D14Ucla3, SP-40, Sgp-2, Sgp2}, GDA (guanine deaminase) [NCBI Gene 9615] {aka CYPIN, GAH, GUANASE, NEDASIN}, PCSK1 (proprotein convertase subtilisin/kexin type 1) [NCBI Gene 5122] {aka BMIQ12, NEC1, PC1, PC1/3, PC3, SPC3}, LRG1 (leucine rich alpha-2-glycoprotein 1) [NCBI Gene 116844] {aka HMFT1766, LRG}, TGFB1 (transforming growth factor beta 1) [NCBI Gene 7040] {aka CAEND1, CED, DPD1, IBDIMDE, LAP, TGF-beta1}, CLU (clusterin) [NCBI Gene 1191] {aka AAG4, APO-J, APOJ, CLI, CLU1, CLU2}, SERPINA1 (serpin family A member 1) [NCBI Gene 5265] {aka A1A, A1AT, AAT, PI, PI1, PRO2275}, Ctnnb1 (catenin beta 1) [NCBI Gene 12387] {aka Bfc, Catnb, Mesc}, FN1 (fibronectin 1) [NCBI Gene 2335] {aka CIG, ED-B, FINC, FN, FNZ, GFND}, Tgfb1 (transforming growth factor, beta 1) [NCBI Gene 21803] {aka TGF-beta1, TGFbeta1, Tgfb, Tgfb-1}, IL6 (interleukin 6) [NCBI Gene 3569] {aka BSF-2, BSF2, CDF, HGF, HSF, IFN-beta-2}, IL17A (interleukin 17A) [NCBI Gene 3605] {aka CTLA-8, CTLA8, IL-17, IL-17A, IL17, ILA17}
- **Diseases:** arthritic (MESH:D015535), OA (MESH:D010003), autoimmune disease (MESH:D001327), swelling (MESH:D004487), tumour (MESH:D009369), pain (MESH:D010146), Inflammatory (MESH:D007249), injury to (MESH:D014947), Fibrosis (MESH:D005355), joint swelling (MESH:D007592), joint deformity (MESH:D016916), arthritis (MESH:D001168), RA (MESH:D001172)
- **Chemicals:** water (MESH:D014867), Methionine (MESH:D008715), Hydrogen (MESH:D006859), Cl- (MESH:D002713), Serine (MESH:D012694), Na+ (MESH:D012964)
- **Species:** Mus musculus (house mouse, species) [taxon 10090], Homo sapiens (human, species) [taxon 9606]
- **Cell lines:** CL-48 — Homo sapiens (Human), Prostate carcinoma, Cancer cell line (CVCL_3872)

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12922013/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12922013/full.md

## References

45 references — full list in the complete paper: https://tomesphere.com/paper/PMC12922013/full.md

---
Source: https://tomesphere.com/paper/PMC12922013